440 related articles for article (PubMed ID: 14966423)
21. Recipient and donor factors influence the incidence of graft-vs.-host disease in liver transplant patients.
Chan EY; Larson AM; Gernsheimer TB; Kowdley KV; Carithers RL; Reyes JD; Perkins JD
Liver Transpl; 2007 Apr; 13(4):516-22. PubMed ID: 17394149
[TBL] [Abstract][Full Text] [Related]
22. Evidence that donor intrinsic response to G-CSF is the best predictor of acute graft-vs-host disease following allogeneic peripheral blood stem cell transplantation.
Dhédin N; Chamakhi I; Perreault C; Roy DC; Sauvageau G; Ducruet T; Busque L; Fish D; Bélanger R; Roy J
Exp Hematol; 2006 Jan; 34(1):107-14. PubMed ID: 16413397
[TBL] [Abstract][Full Text] [Related]
23. The association of CD25 expression on donor CD8+ and CD4+ T cells with graft-versus-host disease after donor lymphocyte infusions.
Mutis T; Aarts-Riemens T; Verdonck LF
Haematologica; 2005 Oct; 90(10):1389-95. PubMed ID: 16219576
[TBL] [Abstract][Full Text] [Related]
24. Development of microchimerism in pediatric patients after living-related liver transplantation.
Ueda M; Hundrieser J; Hisanaga M; Tanaka K; Wonigeit K; Pichlmayr R; Schlitt HJ; Yamaoka Y
Clin Transplant; 1997 Jun; 11(3):193-200. PubMed ID: 9193841
[TBL] [Abstract][Full Text] [Related]
25. Chimerism studies in HLA-identical nonmyeloablative hematopoietic stem cell transplantation point to the donor CD8(+) T-cell count on day + 14 as a predictor of acute graft-versus-host disease.
Petersen SL; Madsen HO; Ryder LP; Svejgaard A; Masmas TN; Dickmeiss E; Heilmann C; Vindeløv LL
Biol Blood Marrow Transplant; 2004 May; 10(5):337-46. PubMed ID: 15111933
[TBL] [Abstract][Full Text] [Related]
26. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.
Farag SS; Bacigalupo A; Eapen M; Hurley C; Dupont B; Caligiuri MA; Boudreau C; Nelson G; Oudshoorn M; van Rood J; Velardi A; Maiers M; Setterholm M; Confer D; Posch PE; Anasetti C; Kamani N; Miller JS; Weisdorf D; Davies SM;
Biol Blood Marrow Transplant; 2006 Aug; 12(8):876-84. PubMed ID: 16864058
[TBL] [Abstract][Full Text] [Related]
27. Early-onset lichenoid graft-vs.-host disease: a unique variant of acute graft-vs.-host disease occurring in peripheral blood stem cell transplant recipients.
Magro CM; Kerns MJ; Votava H; Vasil KE; Dyrsen ME; Morrison CD
J Cutan Pathol; 2010 May; 37(5):549-58. PubMed ID: 19843195
[TBL] [Abstract][Full Text] [Related]
28. Detection of blood chimerism after lung and heart-lung transplantation. The superiority of nested as compared with standard polymerase chain reaction amplification.
Knoop C; Andrien M; Defleur V; Antonine M; de Francquen P; Goldman M; Estenne M
Transplantation; 1994 Dec; 58(12):1335-8. PubMed ID: 7809925
[TBL] [Abstract][Full Text] [Related]
29. Graft-versus-host disease presenting with pancytopenia after en bloc multiorgan transplantation: case report and literature review.
Mawad R; Hsieh A; Damon L
Transplant Proc; 2009 Dec; 41(10):4431-3. PubMed ID: 20005417
[TBL] [Abstract][Full Text] [Related]
30. [Application of sequential and quantitative monitoring of chimerism in allogeneic hematopoietic stem cell transplantation].
Tang XW; Wu DP; Zhu ZL; Wang W; Sun AN; Qiu HY; Fu ZZ; Chang WR; Ruan CG
Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):78-81. PubMed ID: 14990044
[TBL] [Abstract][Full Text] [Related]
31. Unusual onset of chronic graft-versus-host disease after adult living-related liver transplantation from a homozygous donor.
Nemoto T; Kubota K; Kita J; Shimoda M; Rokkaku K; Tagaya N; Fujiwara T; Sunakawa M
Transplantation; 2003 Mar; 75(5):733-6. PubMed ID: 12640319
[TBL] [Abstract][Full Text] [Related]
32. Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors.
Teshima T; Matsuo K; Matsue K; Kawano F; Taniguchi S; Hara M; Hatanaka K; Tanimoto M; Harada M; Nakao S; Abe Y; Wake A; Eto T; Takemoto Y; Imamura M; Takahashi S; Ishida Y; Kanda Y; Kasai M; Takaue Y
Br J Haematol; 2005 Aug; 130(4):575-87. PubMed ID: 16098073
[TBL] [Abstract][Full Text] [Related]
33. CTL clones isolated from an HLA-Cw-mismatched bone marrow transplant recipient with acute graft-versus-host disease.
Sugimoto K; Murata M; Terakura S; Naoe T
J Immunol; 2009 Nov; 183(9):5991-8. PubMed ID: 19812210
[TBL] [Abstract][Full Text] [Related]
34. Efficient identification of T-cell clones associated with graft-versus-host disease in target tissue allows for subsequent detection in peripheral blood.
Beck RC; Wlodarski M; Gondek L; Theil KS; Tuthill RJ; Sobeck R; Bolwell B; Maciejewski JP
Br J Haematol; 2005 May; 129(3):411-9. PubMed ID: 15842666
[TBL] [Abstract][Full Text] [Related]
35. Severe, late-onset graft-versus-host disease in a liver transplant recipient documented by chimerism analysis.
Pollack MS; Speeg KV; Callander NS; Freytes CO; Espinoza AA; Esterl RM; Abrahamian GA; Washburn WK; Halff GA
Hum Immunol; 2005 Jan; 66(1):28-31. PubMed ID: 15620459
[TBL] [Abstract][Full Text] [Related]
36. Cytokine gene expression in peripheral blood mononuclear cells and alloreactivity in hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL; Madsen HO; Ryder LP; Svejgaard A; Dickmeiss E; Vindeløv LL
Biol Blood Marrow Transplant; 2006 Jan; 12(1):48-60. PubMed ID: 16399568
[TBL] [Abstract][Full Text] [Related]
37. Microchimerism after liver transplantation: absence of rejection without abrogation of anti-donor cytotoxic T-lymphocyte-mediated alloreactivity.
Bettens F; Tiercy JM; Campanile N; Giostra E; Majno P; Rubbia L; Roosnek E; Mentha G; Villard J
Liver Transpl; 2005 Mar; 11(3):290-7. PubMed ID: 15719407
[TBL] [Abstract][Full Text] [Related]
38. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].
Chen H; Huang XJ; Liu KY; Xu LP; Wang H; Liu DH; Lu J; Lu DP
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3062-6. PubMed ID: 16324408
[TBL] [Abstract][Full Text] [Related]
39. Severe graft versus host disease following liver transplantation confirmed by PCR-HLA-B sequencing: report of a case and literature review.
Sanchez-Izquierdo JA; Lumbreras C; Colina F; Martinez-Laso J; Jiménez C; Gómez R; García I; Alvarez M; Arnaiz-Villena A; Moreno E
Hepatogastroenterology; 1996; 43(10):1057-61. PubMed ID: 8884339
[TBL] [Abstract][Full Text] [Related]
40. Donor methylenetetrahydrofolate reductase genotype is associated with graft-versus-host disease in hematopoietic stem cell transplant patients treated with methotrexate.
Murphy N; Diviney M; Szer J; Bardy P; Grigg A; Hoyt R; King B; Macgregor L; Holdsworth R; McCluskey J; Tait BD
Bone Marrow Transplant; 2006 Apr; 37(8):773-9. PubMed ID: 16518429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
